The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 24, 2025
Filed:
Feb. 07, 2022
Applicant:
Janssen Pharmaceutica NV, Beerse, BE;
Inventors:
Jose Ignacio Andres Gil, Madrid, ES;
Christa C. Chrovian, La Jolla, CA (US);
Michael A. Letavic, San Diego, CA (US);
Jason C. Rech, San Diego, CA (US);
Dale A. Rudolph, San Diego, CA (US);
Akinola Soyode-Johnson, San Diego, CA (US);
Assignee:
JANSSEN PHARMACEUTICA NV, Beerse, BE;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61P 1/00 (2006.01); A61P 3/10 (2006.01); A61P 7/02 (2006.01); A61P 9/12 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/10 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 17/10 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 25/00 (2006.01); A61P 25/04 (2006.01); A61P 25/08 (2006.01); A61P 25/16 (2006.01); A61P 25/18 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 27/06 (2006.01); A61P 31/00 (2006.01); A61P 31/04 (2006.01); A61P 33/00 (2006.01); A61P 35/00 (2006.01); A61P 37/08 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61P 1/00 (2018.01); A61P 3/10 (2018.01); A61P 7/02 (2018.01); A61P 9/12 (2018.01); A61P 11/00 (2018.01); A61P 11/06 (2018.01); A61P 13/10 (2018.01); A61P 13/12 (2018.01); A61P 17/00 (2018.01); A61P 17/06 (2018.01); A61P 17/10 (2018.01); A61P 19/02 (2018.01); A61P 19/10 (2018.01); A61P 25/00 (2018.01); A61P 25/04 (2018.01); A61P 25/08 (2018.01); A61P 25/16 (2018.01); A61P 25/18 (2018.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 27/06 (2018.01); A61P 31/00 (2018.01); A61P 31/04 (2018.01); A61P 33/00 (2018.01); A61P 35/00 (2018.01); A61P 37/08 (2018.01);
Abstract
The present invention is directed to compounds of Formula (I), which includes enantiomer and diasteromers thereof: The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.